Your session is about to expire
← Back to Search
Stent
Venous Stent Arm for Deep Vein Thrombosis
N/A
Waitlist Available
Led By Dr. Lawrence (Rusty) Hofmann MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights
Summary
To study the safety and efficacy of drug coated stents for the treatment of venous occlusions and stenoses in the lower extremity. The use of the device for the treatment of peripheral arterial disease is approved by the FDA, however, the use of the device in venous occlusions and stenoses, although performed by some practitioners, has not yet been studied in detail.
Eligible Conditions
- Deep Vein Thrombosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Primary Patency Rate
Stent, device
Secondary outcome measures
Adverse Events
Assisted-primary Patency
Decrease in Swelling of Affected Extremity
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Venous Stent ArmExperimental Treatment1 Intervention
The study is a single treatment arm study and the venous stent will be placed in all eligible participants.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,448 Previous Clinical Trials
17,492,393 Total Patients Enrolled
3 Trials studying Deep Vein Thrombosis
295 Patients Enrolled for Deep Vein Thrombosis
Dr. Lawrence (Rusty) Hofmann MDPrincipal InvestigatorStanford University
Share this study with friends
Copy Link
Messenger